Lupus & antiphospholipid syndrome

Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

Continuity of hydroxychloroquine use from preconception through pregnancy reduces preterm birth risk in SLE. Conversely, early exposure to teratogenic immunosuppressants heightens the risk of spontaneous abortion.

Study context

Population
Pregnancies in women with Systemic Lupus Erythematosus (SLE), National Health Information Database, Korea, 2005–2018pregnancies in 3,059 women
Participants
4,880 pregnancies
Exposure
HCQ use patterns and teratogenic immunosuppressant exposure vs continuous HCQ use / no exposure
Outcome
Incidence of APO (preeclampsia/eclampsia, preterm birth, spontaneous abortion, stillbirth)
Methodological detailsnationwide claims database (NHIS Korea, 2005-2018), univariate and multivariable models
  • Nationwide claims database (NHIS Korea, 2005-2018)
  • Univariate and multivariable models

Main finding

As reported in the abstract

Overall APO incidence

Overall adverse pregnancy outcomes (APO) incidence among pregnant women with SLE

45.0%

95% CI 43.4, 46.5%

Observational data: associations, not effects.

Further findings

OutcomeaOR (95% CI)
Preterm birth by HCQ use patternHCQ non-usevs Continuous HCQ1.39 (1.05–1.85)
Preterm birth by HCQ use patternHCQ discontinuationvs Continuous HCQ2.18 (1.61–2.95)
Preterm birth by HCQ use patternHCQ initiation during pregnancyvs Continuous HCQ2.17 (1.16–4.06)

Spontaneous abortion by teratogenic immunosuppressant exposure

aOR
Teratogenic exposure within 3 months of preconception2.59
Teratogenic exposure in first trimester3.18

Original publication

Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea. Rheumatology (Oxford). Published 12 December 2025. doi:10.1093/rheumatology/keaf651

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.